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Objective: To assess the prevalence and risk factors for S. aureus and methicillin-resistant 
S. aureus (MRSA) nasal colonization in Spanish children.
Methods: Cross-sectional study of patients <14 years from primary care centers all over 
Spain. Clinical data and nasal aspirates were collected from March to July 2018.
Results: A total of 1876 patients were enrolled. Prevalence of S. aureus and MRSA 
colonization were 33% (95% CI 30.9–35.1) and 1.44% (95% CI 0.9–2), respectively. Thirty- 
three percent of the children (633/1876) presented chronic conditions, mainly atopic derma-
titis, asthma and/or allergy (524/633). Factors associated with S. aureus colonization were 
age ≥5 years (OR 1.10, 95% CI 1.07–1.12), male sex (OR 1.43, 95% CI 1.17–1.76), urban 
setting (OR 1.46, 95% CI 1.08–1.97) and the presence of asthma, atopic dermatitis or 
allergies (OR 1.25; 95% CI: 1.093–1.43). Rural residence was the only factor associated 
with MRSA colonization (OR 3.62, 95% CI 1.57–8.36). MRSA was more frequently 
resistant than methicillin-susceptible S. aureus to ciprofloxacin [41.2% vs 2.6%; 
p<0.0001], clindamycin [26% vs 16.9%; p=0.39], and mupirocin [14.3% vs 6.7%; p=0.18]. 
None of the MRSA strains was resistant to tetracycline, fosfomycin, vancomycin or 
daptomycin.
Conclusions: The main risk factors for S. aureus colonization in Spanish children are being 
above five years of age, male gender, atopic dermatitis, asthma or allergy, and residence in 
urban areas. MRSA colonization is low, but higher than in other European countries and is 
associated with rural settings.
Keywords: S. aureus, MRSA, child, colonization
Introduction
Staphylococcus aureus is the leading cause of skin and soft tissue infections 
(SSTIs) in children,1 and may cause bacteremia and other invasive diseases such 
as osteoarticular infections and pneumonia.2
For the past 20 years, an increase in both community-associated and hospital- 
acquired infections by S. aureus has been observed,3,4 causing significant morbidity 
and mortality. Methicillin-resistant S. aureus (MRSA) was first isolated in hospita-
lized and chronically ill patients. In the mid-1990s, community-associated cases 
started to emerge leading to changes in empirical treatments in areas where 
methicillin resistance exceeded 10%-15%.
The rate of MRSA among community-acquired S. aureus (CA-MRSA) infection 
in children differs between countries. In Argentina, MRSA causes up to 65% of 
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S. aureus community-acquired bacteremia in children.5 In 
the US, Sutter et al have reported a 31.6% prevalence of 
MRSA in community-onset S. aureus infections in 2014.6 
In Greece, CA-MRSA has been identified in 35% of 
children admitted due to S. aureus osteoarticular infection, 
and in 75% of children with S. aureus pneumonia.3,7 The 
first case of CA-MRSA in a child in Spain was reported in 
2006,8 although current data regarding CA-MRSA infec-
tions in children in our country are scarce.
S. aureus colonization is associated with an increased 
risk of infection and contributes to transmission. Besides, 
it might be an important reservoir of resistance. 
A multicenter study performed in nine European countries 
reported a global prevalence of 21.6% of nasopharyngeal 
colonization by S. aureus. In this study, the prevalence of 
colonization in Spanish children was 31.5%, but the per-
centage of MRSA was not specified.9
In settings with high CA-MRSA prevalence, empirical 
treatment of infections likely caused by S. aureus should 
address this potential threat.10 For all these reasons, we 
designed this study in order to estimate the prevalence of 
MRSA colonization in Spanish children who attend pri-
mary health-care centers for routine health screenings, as 
well as the risk factors associated with CA-MRSA nasal 
carriage. This will help to establish a proper empirical 
therapeutic approach in children with suspected commu-
nity-acquired S. aureus infections.
Methods
We conducted a nationwide observational, cross-sectional 
multicenter study in children from community settings all 
over Spain (the COSACO study –Colonization by 
S. aureus in the Community). All research was performed 
in accordance with local regulations. Informed consent in 
accordance with the Declaration of Helsinki was obtained 
from the parents or guardians of all children before their 
inclusion, as well as from those patients aged 12 years or 
older. The study was approved by the Clinical Research 
Ethics Committee at La Paz University Hospital (Madrid) 
(PI18/00372).
Study Participants
Between March and July 2018, children under 14 years of 
age attending primary care for routine preventive assess-
ments were recruited. Children presenting with an active 
infection during the visit (either confirmed or suspected) 
were excluded from the study. Seventy primary care cen-
ters from all the Spanish regions took part in the study. 
According to region features and population density, at 
least two health-care centers (from rural, urban and 
mixed areas) were selected to take part in the study. The 
number of included patients was proportional to the pedia-
tric population living in that region.
Primary care pediatricians from a pre-existing research 
network (PAPenRED) recruited patients in accordance 
with the study protocol, which included a homogeneous 
age distribution. Children were included every Tuesday 
and Thursday until recruitment was completed. Sample 
size was calculated for a 95% confidence level and a 3% 
margin of error, assuming a prevalence of nasal coloniza-
tion of 20% for S. aureus and of 3% for MRSA. According 
to these data and taking into account a 15% of possible 
losses during the inclusion process, a minimum target of 
1745 samples was established.
A survey was performed for each patient to collect 
clinical and epidemiological data including age; gender; 
siblings; household members; habitat type; child’s and 
parents’ origin; school/day-care attendance; exposure to 
livestock or pets; underlying chronic conditions; hospital 
admissions; antibiotic treatment in the previous month; 
and/or previous skin infections affecting the child or any 
of the household members.
Study Samples
Nasal swabs from every patient were collected following 
a standardized protocol, inserting the swab tip into the two 
nostrils and rotating it for five seconds in each one. 
ESwabTM flocked swabs with Liquid Amies Medium 
(Copan, Brescia, Italy) were used. Nasal samples were 
submitted from each primary care center to its microbiol-
ogy laboratory of reference belonging to hospitals of the 
National Health Service in Spain. Isolation and identifica-
tion of S. aureus were based on standard microbiological 
procedures. For methicillin resistance screening, disk dif-
fusion method with cefoxitin (30 µg) was used. 
Susceptibility testing to other antibiotics was performed 
by microdilution or disk diffusion. Methods and antimi-
crobial susceptibility interpretations were in accordance 
with the EUCAST guidelines.11
Statistical Analysis
Values are expressed as percentages for discrete variables 
or as the mean and standard deviation for continuous 
variables. Categorical variables were compared using χ2 
and Fisher’s exact test, and continuous variables with 
Student’s t test or non-parametric tests, as appropriate. 
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Logistic regression for multivariate analysis was per-
formed according to the distribution and characteristics 
of the variables. A two-sided value of p≤ 0.05 was con-
sidered statistically significant. Odds ratio (OR) was used 
as measures of association, with 95% confidence interval 
(CI) to assess its precision. All analyses were performed 
using the Statistical Package for the Social Sciences, ver-
sion 21.0 (IBM, Armonk, NY).
Results
We included 1876 children and their corresponding sam-
ples. The epidemiological and clinical characteristics of 
the cohort are shown in Table 1. A total of 619 samples 
were positive, meaning that 33% of children (95% CI: 
30.9–35.1) were colonized by S. aureus. MRSA was iso-
lated in 27/619 positive samples (4.4%; 95% CI: 2.7–6.0). 
This implies an MRSA colonization prevalence of 1.4% in 
Spanish children (95% CI: 0.9–2.0).
The comparison of the epidemiological features of 
colonized and non-colonized children is shown in 
Table 2. In the univariate analysis, children colonized 
by S. aureus were: older than 5 years of age; males; 
living in urban settings; attending school or daycare and 
having previous skin infections or underlying chronic 
conditions more frequently than non-colonized patients. 
Logistic regression analysis indicated a significantly 
higher risk of colonization by S. aureus for children 
older than five years of age, males, living in urban 
settings and with chronic diseases (Table 2). Thirty- 
three percent of the children included in the study pre-
sented some type of chronic condition (633/1876), 
mostly atopic dermatitis, asthma and/or allergy (82.7%; 
524/633). The presence of asthma, atopic dermatitis or 
allergies increased the risk of S. aureus colonization 
(OR 1.25; 95% CI: 1.093–1.43).
S. aureus colonization prevalence by age and sex is 
reported in Supplementary materials (https://www.dove 
press.com/get_supplementary_file.php?f=282880.pdf). In 
children older than 10 years, we observed the greatest 
difference in the colonization rate between males and 
females [49.3% vs 31.7%; OR 2.09 (95% CI; 1.49– 
2.94)]. In our cohort, the number of household members 
and siblings, foreign origin of children or parents, live-
stock or pet exposure and antibiotic treatment in the pre-
vious month had no impact on the carrier status.
Regarding MRSA colonization, a significantly higher rate 
was observed among children living in rural environments 
(OR 3.49; 95% CI: 1.46–8.37) (Supplementary materials 
https://www.dovepress.com/get_supplementary_file.php?f= 
282880.pdf). No other risk factors related to CA-MRSA colo-
nization were found. Children aged 0–4 years had a CA- 
MRSA colonization rate of 7.4% (9/122), whereas 5–9 years 
and 10–14 years had 3.4% (9/263) and 3.8% (9/234) 
Table 1 Epidemiological and Clinical Characteristics of the Study 
Cohort (n=1876)
n (%)
Age group (years) 0–4 651 (34.7)
5–9 647 (34.5)
10–14 578 (30.8)
Mean age in years (SD)* 7.01 (4.38)
Female gender 946 (50.4)
Child’s origin Foreign 77 (4.1)
Spanish 1799 (95.9)
Mother’s origin Foreign 387 (20.6)
Spanish 1489 (79.4)
Father’s origin Foreign 357 (19)
Spanish 1519 (81)





Mean number of individuals per household (SD) 4.01 (0.99)
Habitat type Rural 296 (15.8)
Urban 1188 (64.3)
Mixed 392 (20.9)
Livestock exposure 192 (10.2)
Pets at home 867 (46.2)
School or daycare attendance 1539 (82)
Antibiotic treatment in the previous month 105 (5.6)









Hospital admission in the last year 97 (5.2)
Underlying chronic 
disease
Atopic dermatitis (with 
no other atopic 
manifestations)
316 (16.8%)
Asthma and/or allergies 208 (11.1%)
Others 109 (5.8%)
Abbreviation: SD, standard deviation.
Infection and Drug Resistance 2020:13                                                                                     submit your manuscript | www.dovepress.com                                                                                                                                                                                                                       
DovePress                                                                                                                       
4645



































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Table 2 Variables Analyzed as Possible Risk Factors for S. aureus Colonization
Total Population (n=1876) S. aureus Colonized (n=619) 
n (%) (95% CI) or Mean (SD)
Magnitude (CI 95%)
Age group (years) 0–4 (n=651) 122 (18.7) (15.7–21.7) OR 5–14 years: 2.96 (2.36–3.72)*
5–9 (n=647) 263 (40.7) (36.9–44.4)
10–14 (n=578) 234 (40.5) (36.5–44.5)
Mean age 
(years)
Colonized 8.19 (3.96) MD: 1.75 (1.35–2.15)*
Not colonized 6.44 (4.50)
Gender Male (n=930) 339 (36.5) (33.4–39.5) OR male: 1.36 (1.12–1.66)*
Female (n=946) 280 (29.6) (26.7–32.1)
Child’s origin Foreign (n=77) 26 (33.8) (23.2–44.3) OR: 1.04 (0.64–1.68)
Spanish (n=1799) 591 (32.8) (30.8–35.1)
Mother’s origin Foreign (n=387) 115 (29.7) (25.2–34.3) OR: 0.83 (0.65–1.05)
Spanish (n=1489) 502 (33.7) (31.4–36.2)
Father’s origin Foreign (n=357) 123 (34.5) (29.5–39.4) OR: 1.09 (0.85–1.38)
Spanish (n=1519) 494 (32.5) (30.3–35.0)
Number of siblings Colonized 2.00 (0.98) MD: 0.03 (−0.07–0.13)
Not colonized 1.97 (1.01)
People per household Colonized 4.03 (0.95) MD: 0.03 (−0.06–0.12)
Not colonized 4.00 (1.01)
Habitat Urban (n=1580) 538 (34) (31.7–36.4) OR urban: 1.37 (1.03–1.81)*
Rural (n=296) 81 (27.4) (22.3–32.4)
Livestock exposure Yes (n=192) 66 (34.4) (27.7–44.1) OR: 1.07 (0.78–1.47)
No (n=1679) 553 (32.9) (30.6–35.1)
Pets at home Yes (n=867) 282 (32.5) (29.4–35.6) OR: 0.97 (0.80–1.18)
No (n=1002) 333 (33.2) (30.3–36.2)
School/daycare attendance Yes (n=1539) 551 (35.8) (33.4–38.2) OR 2.19 (1.65–2.92)*
No (n=336) 68 (20.2) (16.0–24.5)
Previous antibiotic treatment Yes (n=105) 28 (56.7) (18.2–35.1) OR no antibiotic: 1.38 (0.88–2.15)
No (n=1761) 588 (33.4) (31.2–35.6)
Previous skin infection Yes (n=361) 136 (37.7) (32.8–42.8) OR: 1.29 (1.01–1.63)*
No (n=1418) 455 (32,1) (29.7–34.6)
Hospital admission last year Yes (n=97) 26 (26.8) (18.0–35.6) OR: 1.36 (0.86–2.16)
No (n=1774) 591 (33.3) (31.1–35.5)
Underlying chronic disease Yes (n=633) 242 (38.2) (34.7–42.3) OR: 1.44 (1.18–1.76)*
No (n=1240) 375 (30.2) (27.7–32.8)
MULTIVARIATE ANALYSIS
Age OR: 1.10 (1.07–1.12)*
Male gender OR: 1.43 (1.17–1.76)*
Urban habitat OR: 1.46 (1.08–1.97)*
Underlying chronic disease OR: 1.27 (1.02–1.57)*
Note: *Significant results are represented in bold letters. 
Abbreviations: SD, standard deviation; MD, mean difference; OR, odds ratio; CI, confidence interval.
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respectively, although this trend was not statistically signifi-
cant [OR 0–4 years vs 5–14: 2.12 (0.93–8.45)].
Antibiotic susceptibility results are shown in Figure 1 
and Supplementary materials (https://www.dovepress.com/ 
get_supplementary_file.php?f=282880.pdf). MRSA was 
more frequently resistant than methicillin-susceptible 
S. aureus (MSSA) to other antibiotics, including ciproflox-
acin [41% (7/17) vs 2.6% (10/384); p<0.0001], erythro-
mycin [34% (8/23) vs 22% (114/507); p=0.17], 
clindamycin [26% (6/23) vs 16.9% (85/504); p=0.39], 
and mupirocin [14.3% (3/21) vs 6.7% (31/462); p=0.18]. 
None of the MRSA strains associated resistance to tetra-
cycline (n=13), fosfomycin (n=17), vancomycin (n=21) or 
daptomycin (n=20). Only one out of 18 strains was line-
zolid-resistant.
Discussion
This is the first study performed in Spain to determine the 
national prevalence and antibiotic resistance of commensal 
S. aureus in children, and one of the largest in Europe 
analyzing more than 1,800 nasal swabs obtained in pri-
mary care centers. The prevalence of nasal carriage was 
higher than 30% among Spanish children. The main risk 
factors for colonization were: age above 5 years; male 
gender; atopic dermatitis; asthma or allergy and residence 
in urban areas. MRSA prevalence was 1.4% and increased 
among children younger than 4 years and those living in 
rural areas.
Older children and young adults, as well as males, are 
known to be more frequently colonized by S. aureus.9,12–15 
As we have observed, other authors have also reported 
higher colonization rates in urban settings in asymptomatic 
children or among adults with SSTIs.16,17 In our study, 
patients with chronic conditions presented higher rates of 
colonization, although most of them were atopic children. 
Patients with atopic dermatitis are mainly colonized by 
S. aureus, in contrast to children with healthy skin, who 
are more frequently colonized by S. epidermidis or 
Figure 1 Antibiotic susceptibility results of methicillin-susceptible S. aureus (A) and methicillin-resistant strains (B).
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S. hominis.18 It has been described in the past that early- 
life skin colonization by S. aureus may contribute to the 
onset of atopic dermatitis.18 S. aureus colonization has 
also been associated with asthma, food sensitization and 
allergy.19,20 As neither previous antibiotic treatments nor 
hospital admissions were associated with colonization, 
atopy itself seems to increase the risk for S. aureus colo-
nization, and no other chronic conditions with frequent use 
of health-care services.
Higher colonization prevalence has also been reported 
among patients with SSTIs compared to controls.17 In our 
study, previous SSTI was a risk factor for colonization in 
univariate analysis but not in logistic regression analysis. 
Nevertheless, as patients with atopic dermatitis suffer 
more SSTIs than non-atopic children,18 it is likely that 
atopy is the real risk factor for colonization, as we have 
previously mentioned. Several authors have reported that 
children living in crowded settings or attending school are 
more likely to be colonized,15,21,22 as these settings 
increase human contact and the possibility of transmission. 
The contamination of inert surfaces and objects could have 
a major role in cross-transmission of pathogens in school 
settings, as with nosocomial infection acquisition.23 Some 
of the Staphylococcus strains have the ability to produce 
biofilms, which allow the bacteria to adhere to surfaces 
and foreign bodies. This is a virulence factor, which favors 
subsequent colonization and infection as previously 
reported.24 Univariate analysis revealed that colonized 
children attended school or daycare more frequently than 
non-colonized ones, although this could not be proved by 
logistic regression analysis. Maternity leave lasted less 
than 20 weeks in our country, and following this period, 
many infants were admitted to day-care centers.25 Almost 
all children go to school at the age of three in our country 
(96.5%),25 which could favor higher colonization rates.
Regarding CA-MRSA, multiple factors have been pro-
posed that increase the risk of colonization, such as low 
socioeconomic status, living in crowded conditions, pre-
vious exposure to antibiotics and livestock exposure or 
pets.26–30 In our cohort, we observed a higher percentage 
of MRSA carriage among children younger than 4 years 
of age.
Our observation is coincident with that reported by 
other authors, who have observed higher rates of CA- 
MRSA infections in younger children,6,27 as higher colo-
nization rates seem to increase the risk for subsequent 
infections.18 We did not find any other epidemiological 
factors that increased the risk of MRSA carriage, except 
for children living in rural areas, although the low number 
of MRSA strains isolated in our study could be a limitation 
for relevant conclusions.
None of the MRSA strains was associated with tetra-
cycline resistance, a marker of livestock-associated 
MRSA.31 In addition, no relationship was observed 
between the presence of pets in the household and 
MRSA colonization, suggesting that MRSA carriage is 
not a zoonotic problem among Spanish children.
In 2013, den Heijer et al reported the results of a large 
cross-sectional study (APRES study)9 performed by 
family doctors that compared the prevalence of nasal 
S aureus carriage in patients (aged 4 years or older) across 
nine European countries, including Spain. More than 4,000 
Spanish patients were included, but only 12% were 
younger than 20 years. The global prevalence of 
S. aureus nasopharyngeal colonization was 19% in our 
country, but it was higher in populations between 4 and 
19 years of age (31.5%). MRSA was isolated in 0.3% of 
the Spanish patients.
We have observed a slightly higher prevalence of 
S. aureus colonization in Spanish children, even with 
younger patients included in our study who usually have 
lower colonization rates, as we have previously described. 
Recent studies performed in different regions of Europe 
have also reported high S. aureus colonization rates in 
children (34% to 53%).13,32 These data suggest that 
S. aureus colonization could be increasing in children in 
our continent. In addition, although the isolation of MRSA 
was low in our cohort (1.4%), it is substantially higher 
than the rates reported by several authors in European 
children and even in adults (0.14–0.8%)9,13,26,32 which is 
a concerning issue.
S. aureus carriage increases the risk of subsequent 
S. aureus infections,14,29,33 and most of the children who 
develop life-threatening S. aureus infections are young and 
previously healthy.6,27 Accordingly, the surveillance of 
S. aureus and MRSA colonization in children is important.
In the last decades, countries in the American continent 
and in the Asia–Pacific region have faced a dramatic 
increase of infections caused by CA-MRSA 
strains,27,29,34–36 which has led to changes in the initial 
empirical treatment upon S. aureus suspicion.35 In Europe, 
surveillance data show a general trend towards increasing 
MRSA infection from north to south, with higher preva-
lence in Spain, Italy and Greece.29 Several authors have 
reported high rates of MRSA in community-associated 
infections in children in southern Europe, with high ICU 
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admission rates and longer hospitalizations.3,7 The differ-
ent prevalence rates observed across Europe could be 
explained by different lifestyle conditions, infection con-
trol practices and antimicrobial use.9,15,26,29 Spain was the 
country with the highest rate of antibiotic use per habitant 
of all the countries included in the APRES study. It was 
also the one with the lowest percentage of pan-susceptible 
S. aureus strains.9 Our study found a higher resistance to 
clindamycin, ranging from 17% in MSSA to 26% in 
MRSA strains. Several authors have also reported 
a worrisome increase in clindamycin resistance in both 
MSSA and MRSA strains isolated from children with 
S. aureus infection in different countries. These rates 
were much higher than 15%,6,7,37 exceeding 30% to 50% 
in some cases.6 We have additionally observed a high 
erythromycin resistance rate in our study, especially in 
MRSA strains, which can imply inducible clindamycin 
resistance. For all these reasons, when the local suscept-
ibility rate drops below 85%, clinicians should not use 
clindamycin in the empirical treatment of S. aureus 
infections,6 unless inhibition of toxin production is 
required.38
Rapid development of resistance to mupirocin has also 
been described over the last years.6,39,40 As intranasal 
mupirocin is the cornerstone for eradication therapy, the 
increasing rates of resistance are worrisome.40 Less than 
1% of S. aureus strains from our study were resistant to 
sulfamethoxazole/trimethoprim, similarly to other European 
studies.9,38 This antibiotic can be a good alternative for non- 
severe infections, as its efficacy is similar to clindamycin.41
Our study has some limitations. Samples were taken 
only from the anterior nares, leaving out other sites of 
colonization such as throat, groin, perineal region or rec-
tum. Some authors have reported that oropharyngeal 
screening could increase the identification of S. aureus 
carriage by about 14%, since some children are colonized 
exclusively in the throat.33 Previous studies have reported 
that staphylococcal strains colonizing the pharynx display 
more aggressive traits compared to those colonizing the 
anterior nares, which might have important implications 
on the risk of developing disease following colonization.42 
Therefore, we could have underestimated the prevalence 
of S. aureus colonization in Spanish children. Secondly, 
we were not able to demonstrate a different rate of colo-
nization in children of foreign origin, although the risk of 
CA-MRSA infection is higher in patients from Latin 
America and very low in Sub-Saharan Africa.43 As only 
4% of our patients were immigrants, a comparison 
between individual countries was not feasible.
The microbiological methods were not performed in 
a single reference laboratory, which could have contribu-
ted to homogenizing study results. However, we chose to 
carry out the microbiological studies in each primary care 
centers’ reference laboratories to facilitate the organization 
and execution of the study. All the participating labora-
tories were accredited to carry out these microbiological 
procedures.
The 27 strains of MRSA detected in the study were not 
typified, which would have made it possible to confirm the 
community origin of the strains, or to suggest the possible 
hospital or livestock association. The epidemiology of 
MRSA is transforming into a blurry boundary between 
HA-MRSA and CA-MRSA due to a constant transfer of 
strains between the community and hospitals, as pre-
viously documented.44 Nevertheless, the main strength of 
this surveillance study is that it includes children of all 
ages, who live in rural and urban settings all over Spain. It 
provides important and reliable information regarding 
S. aureus carriage in the pediatric population, as well as 
updated and relevant antibiotic resistance data in 
a European Mediterranean country.
Abbreviations
CA, community-acquired; CI, confidence interval; 
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